Performing an appropriate risk management methodology is essential to support early decision-making in innovation development projects.In parallel,research and practice in innovation have evolved over the last years,s...
supported by Noncommunicable Chronic Diseases-National Science and Technology Major Program(Grant No.2023ZD0509600);Researcher at the Chinese Academy of Sciences Think Tank on the Issues and Countermeasures in the Development of Innovative Drugs in China(Grant No.2023-ZY06-B-032).
Access to medicines for children is a critical global issue that demands urgent attention.In China,the need is particularly acute due to its large pediatric population and corresponding clinical demand.This study aime...
The development of communication networks is currently undergoing a period of transformation.This paper illustrates this transformation from the growth rate of communication users,network bandwidth,and service revenue...
Liaoning Science Public Welfare Research Fund(Soft Science Research Program)in 2022(No.2022JH4/10100040).
Objective To study the effect of government R&D funding and enterprise R&D input on innovation efficiency of China’s pharmaceutical industry.Methods Based on the inter-provincial panel data of China’s pharmaceutical...